What's breaking now, across thousands of outlets.
(MedPage Today) -- Perioperative treatment with durvalumab (Imfinzi) plus neoadjuvant enfortumab vedotin (EV) significantly improved event-free survival (EFS) and overall survival (OS) compared with radical cystectomy in patients with muscle-invasive...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
Health Cabinet Secretary Aden Duale has said Kenya has contained the Ebola threat, expressing confidence that the country will be declared free of the disease after completing the World Health…
A multicentre study found that nearly one in 11 high-risk hospitalised adults had melioidosis, with almost one in five confirmed patients dying in hospital.
Read the latest news as the FG approves a N100,000 weekly Ebola stipend for contacts and gospel singer Tope Alabi threatens a lawsuit over death claims.
(MedPage Today) -- DENVER -- Significant proteinuria reductions were reported in phase III interim analyses assessing two investigational IgA nephropathy agents and a third that was recently granted…
Personalized Moderna and Merck vaccine, called intismeran, was made with same Nobel Prize-winning mRNA technology behind COVID-19 vaccines
(MedPage Today) -- "The cat is out of the bag." -- Adam Waickman, PhD, of SUNY Upstate Medical University in Syracuse, New York, discussing the large dengue outbreaks in Florida and warning of further…
